Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

1.

Genetic and epigenetic deregulation are associated with the aberrant expression of a stem cell related hox gene signature in glioblastoma.

Hegi ME, Kurscheid S, Sciuscio D, Samarzija I, Stupp R, Delorenzi M.

Neuro Oncol. 2014 Jul;16 Suppl 3:iii8. doi: 10.1093/neuonc/nou206.26.

PMID:
25165374
[PubMed - in process]
2.

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.

Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, Lhermitte B, Pietsch T, Grujicic D, Steinbach JP, Wick W, Tarnawski R, Nam DH, Hau P, Weyerbrock A, Taphoorn MJ, Shen CC, Rao N, Thurzo L, Herrlinger U, Gupta T, Kortmann RD, Adamska K, McBain C, Brandes AA, Tonn JC, Schnell O, Wiegel T, Kim CY, Nabors LB, Reardon DA, van den Bent MJ, Hicking C, Markivskyy A, Picard M, Weller M; for the European Organisation for Research and Treatment of Cancer (EORTC); the Canadian Brain Tumor Consortium, and the CENTRIC study team.

Lancet Oncol. 2014 Aug 19. pii: S1470-2045(14)70379-1. doi: 10.1016/S1470-2045(14)70379-1. [Epub ahead of print]

PMID:
25163906
[PubMed - as supplied by publisher]
3.

EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.

Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, Cohen-Jonathan-Moyal E, Frappaz D, Henriksson R, Balana C, Chinot O, Ram Z, Reifenberger G, Soffietti R, Wick W; for the European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma.

Lancet Oncol. 2014 Aug;15(9):e395-e403. doi: 10.1016/S1470-2045(14)70011-7. Review.

PMID:
25079102
[PubMed - as supplied by publisher]
4.

The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review.

Dirven L, Taphoorn MJ, Reijneveld JC, Blazeby J, Jacobs M, Pusic A, La Sala E, Stupp R, Fayers P, Efficace F; EORTC Quality of Life Group (Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Registry).

Eur J Cancer. 2014 Jul 14. pii: S0959-8049(14)00760-6. doi: 10.1016/j.ejca.2014.06.016. [Epub ahead of print] Review.

PMID:
25034656
[PubMed - as supplied by publisher]
5.

European perspective for effective cancer drug development.

Lacombe D, Tejpar S, Salgado R, Cardoso F, Golfinopoulos V, Aust D, Folprecht G, Roth A, Stupp R.

Nat Rev Clin Oncol. 2014 Aug;11(8):492-8. doi: 10.1038/nrclinonc.2014.98. Epub 2014 Jun 17.

PMID:
24935010
[PubMed - in process]
6.

Addition of lomustine for bevacizumab-refractory recurrent glioblastoma.

Tonder M, Eisele G, Weiss T, Hofer S, Seystahl K, Valavanis A, Stupp R, Weller M, Roth P.

Acta Oncol. 2014 May 26:1-4. [Epub ahead of print] No abstract available.

PMID:
24862539
[PubMed - as supplied by publisher]
7.

Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target.

Stupp R, Weller M.

Neuro Oncol. 2014 Jun;16(6):765-7. No abstract available.

PMID:
24826844
[PubMed - in process]
8.

High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G; on behalf of the ESMO Guidelines Working Group.

Ann Oncol. 2014 Apr 29. [Epub ahead of print] No abstract available.

PMID:
24782454
[PubMed - as supplied by publisher]
9.

Reply to M.C. Chamberlain.

Gilbert MR, Dignam J, Pugh S, Armstrong TS, Wefel JS, Aldape K, Stupp R, Hegi M, Won M, Curran WJ, Mehta MP.

J Clin Oncol. 2014 May 20;32(15):1634-5. doi: 10.1200/JCO.2013.54.9717. Epub 2014 Apr 21. No abstract available.

PMID:
24752060
[PubMed - indexed for MEDLINE]
10.

Combination of MRI and dynamic FET PET for initial glioma grading.

Dunet V, Maeder P, Nicod-Lalonde M, Lhermitte B, Pollo C, Bloch J, Stupp R, Meuli R, Prior JO.

Nuklearmedizin. 2014 Aug 6;53(4):155-61. doi: 10.3413/Nukmed-0650-14-03. Epub 2014 Apr 16.

PMID:
24737132
[PubMed - in process]
11.

Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients.

Hundsberger T, Tonder M, Hottinger A, Brügge D, Roelcke U, Putora PM, Stupp R, Weller M.

J Neurooncol. 2014 Jun;118(2):321-8. doi: 10.1007/s11060-014-1434-1. Epub 2014 Apr 16.

PMID:
24736829
[PubMed - in process]
12.

Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials.

Zikos E, Ghislain I, Coens C, Ediebah DE, Sloan E, Quinten C, Koller M, van Meerbeeck JP, Flechtner HH, Stupp R, Pallis A, Czimbalmos A, Sprangers MA, Bottomley A.

Lancet Oncol. 2014 Feb;15(2):e78-89. doi: 10.1016/S1470-2045(13)70493-5. Review.

PMID:
24480558
[PubMed - indexed for MEDLINE]
13.

Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression.

Eisele G, Wick A, Eisele AC, Clément PM, Tonn J, Tabatabai G, Ochsenbein A, Schlegel U, Neyns B, Krex D, Simon M, Nikkhah G, Picard M, Stupp R, Wick W, Weller M.

J Neurooncol. 2014 Mar;117(1):141-5. doi: 10.1007/s11060-014-1365-x. Epub 2014 Jan 19.

PMID:
24442484
[PubMed - in process]
14.

Standards of care and novel approaches in the management of glioblastoma multiforme.

Hottinger AF, Stupp R, Homicsko K.

Chin J Cancer. 2014 Jan;33(1):32-9. doi: 10.5732/cjc.013.10207.

PMID:
24384238
[PubMed - in process]
Free PMC Article
15.

Treatment of primary CNS lymphoma.

Roth P, Stupp R, Eisele G, Weller M.

Curr Treat Options Neurol. 2014 Jan;16(1):277. doi: 10.1007/s11940-013-0277-y.

PMID:
24343307
[PubMed]
16.

Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.

Rossetti AO, Jeckelmann S, Novy J, Roth P, Weller M, Stupp R.

Neuro Oncol. 2014 Apr;16(4):584-8. doi: 10.1093/neuonc/not170. Epub 2013 Dec 4.

PMID:
24311644
[PubMed - in process]
17.

The accuracy of predicting survival in individual patients with cancer.

Kondziolka D, Parry PV, Lunsford LD, Kano H, Flickinger JC, Rakfal S, Arai Y, Loeffler JS, Rush S, Knisely JP, Sheehan J, Friedman W, Tarhini AA, Francis L, Lieberman F, Ahluwalia MS, Linskey ME, McDermott M, Sperduto P, Stupp R.

J Neurosurg. 2014 Jan;120(1):24-30. doi: 10.3171/2013.9.JNS13788. Epub 2013 Oct 25.

PMID:
24160479
[PubMed - indexed for MEDLINE]
18.

Malignant astrocytoma in elderly patients: where do we stand?

Tabatabai G, Stupp R, Wick W, Weller M.

Curr Opin Neurol. 2013 Dec;26(6):693-700. doi: 10.1097/WCO.0000000000000037. Review.

PMID:
24152817
[PubMed - indexed for MEDLINE]
19.

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, Tzuk-Shina T, Brown PD, Chakravarti A, Curran WJ Jr, Mehta MP.

J Clin Oncol. 2013 Nov 10;31(32):4085-91. doi: 10.1200/JCO.2013.49.6968. Epub 2013 Oct 7.

PMID:
24101040
[PubMed - indexed for MEDLINE]
20.

New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials.

Gorlia T, Wu W, Wang M, Baumert BG, Mehta M, Buckner JC, Shaw E, Brown P, Stupp R, Galanis E, Lacombe D, van den Bent MJ.

Neuro Oncol. 2013 Nov;15(11):1568-79. doi: 10.1093/neuonc/not117. Epub 2013 Sep 18.

PMID:
24049111
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk